1133 related articles for article (PubMed ID: 17991319)
21. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
22. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
23. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach.
Teixeira A; David L; Reis CA; Costa J; Sobrinho-Simões M
J Pathol; 2002 May; 197(1):37-43. PubMed ID: 12081201
[TBL] [Abstract][Full Text] [Related]
24. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
25. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
26. [Expression of human pituitary tumor transforming gene 1 in colorectal cancer detected with real-time fluorescent quantitative PCR and its clinical significance].
Wu BW; Ma D; Li DF; Li YJ; Deng G; Zeng ZG; Zhang KJ; Zhang YH; Geng QS
Ai Zheng; 2008 Nov; 27(11):1217-21. PubMed ID: 19000457
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
28. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
Kim D; Jung WH; Koo JS
Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
[TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
30. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
Vernygorodskyi S
Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
[TBL] [Abstract][Full Text] [Related]
32. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
[TBL] [Abstract][Full Text] [Related]
33. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
Dong Y; Walsh MD; Cummings MC; Wright RG; Khoo SK; Parsons PG; McGuckin MA
J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
[TBL] [Abstract][Full Text] [Related]
34. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract][Full Text] [Related]
35. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
37. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
38. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
[TBL] [Abstract][Full Text] [Related]
40. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
